Authors
Kopylova A. I.
Ph.D. (Pharmacy), Assistant, Chair for Chemistry and Pharmacognosy1
Kobeleva T. A.
Doctor of Pharmacy, Professor, Head, Chair for Chemistry and Pharmacognosy1
Sichko A. I.
Doctor of Pharmacy, Professor, Professor, Chair for Chemistry and Pharmacognosy1
1 - Tyumen State Medical University, Tyumen, Russian Federation
Corresponding Author
Kopylova Anna; e-mail: KopylovaAI@tyumsmu.ru.
Funding
The study had no sponsorship.
Conflict of interest
None declared.
Abstract
Introduction. For the introduction of new medicines into medical practice, a mandatory stage is quality control, which includes determining the quantitative content of active components using modern methods of pharmaceutical analysis. Tizol gel, included in soft dosage forms, is an independent pharmacologically active agent, therefore it is important to evaluate its content in complex medicinal preparations. Aim. To develop a method for quantitative determination of tizol gel and metronidazole in a new semisolid dosage form «Metronidazole» using multiple-wavelength spectrophotometry. Materials and methods. Pharmaceutical substance metronidazole, tizol gel, «Metronidazole» ointment containing 5% nitroimidazole in a tizol base was used for analysis. The studies were performed on spectrophotometer SF-2000 by multiple-wavelength spectrophotometry in the UV region. On the basis of experimental data, the metrological parameters of the developed analytical technique were calculated. Results and discussion. Experimental studies allowed us to justify the use of an acetate buffer solution with pH = 4 as the optimum solvent for the spectrophotometric analysis of tisol gel and metronidazole in the mixture. Analytical wavelengths (238 nm for tisol gel, 316 nm for metronidazole) were selected according to the UV spectra of the drugs obtained. According to the results of quantitative determination of the components of the Metronidazole ointment, the content of medicines is within the limits: metronidazole from 0.4900 to 0.5219 g, tizol gel (in terms of the mass fraction of titanium) – 2.32–2.46%, which are acceptable according to regulatory documentation (FSF 42-3157-06, OFS.1.8.0001). Conclusion. Quantitative analysis of tisol gel in complex pharmaceutical preparations was proposed for the first time. The method of quantitative determination by multiple-wavelength spectrophotometry has been developed which allows to determine the content of tizol gel and metronidazole in a new semisolid dosage form «Metronidazole» with relative errors of the average result not exceeding ± 3.00%.
Key words
metronidazole, tizol gel, multiwave spectrophotometry, quantitative determination
DOI
References
1. Gosudarstvennaja farmakopeja Rossijskoj Federacii. XV izdanie. [The State Pharmacopoeia of the Russian Federation 15th edition]. Available at: https://pharmacopoeia.regmed.ru/pharmacopoeia/izdanie-15. Accessed: 06.06.2024. (In Russ.)
2. Elovikova T.M., Grigor'ev S.S., Sablina S.N., Ermishina E.Ju. Tradicii i innovacii parodontologii: akvakompleks glicerosol'vata titana. [The use of the drug tizol in periodontology, medicine and pharmacy, manual prescriptions of a mild dosage form based on it]. Ekaterinburg: Ural'skij gosudarstvennyj medicinskij universitet, 2023. 200 s. (In Russ.)
3. Zamaraeva A.I. Perspektivy ispol'zovanija spektrofotometrii i himicheskih metodov v analize i izuchenii svojstv novyh mjagkih lekarstvennyh form, izgotovlennyh na glicerogidrogele «Tizol'». [The use of spectrophotometry and chemical methods in the analysis and study of the properties of new soft dosage forms made with Tizol gel]. Voprosy biologicheskoj, medicinskoj i farmacevticheskoj himii [Issues of biological, medical and pharmaceutical chemistry] 2022; 25 (9): 26-33. (In Russ.)
4. Kobeleva T.A., Sichko A.I., Zamaraeva A.I., Bessonova N.S. Razrabotka sposoba analiza ofloksacina v kompleksnom preparate «Ofloksazol'». [Development of a method for the analysis of ofloxacin in the complex preparation «Ofloxazole»]. Razrabotka i registracija lekarstvennyh sredstv [Development and registration of medicines] 2021; 10(3): 70-75. (In Russ.)
5. Kobeleva T.A., Sichko A.I., Kopylova A.I., Popova M.I., inventors; FGBOU VO «Tjumenskij gosudarstvennyj medicinskij universitet» Ministerstva Zdravoohranenija Rossijskoj Federacii, patentoobladatel'. Sposob kolichestvennogo opredelenija lekarstvennogo preparata Tizol'® gelja. [The method of quantitative determination of the drug Tizol® gel]. Russian Federation patent RU 2812613 S1. – ¹ 2023117934. 30 Jan 2024. (In Russ.)
6. Kopylova A.I., Popova M.I., Kobeleva T.A., Sichko A.I., Emel'janov A.A. Ispol'zovanie sovremennyh transdermal'nyh provodnikov v izgotovlenii mjagkih lekarstvennyh form. [The use of modern transdermal conductors in the manufacture of soft dosage forms]. Voprosy obespechenija kachestva lekarstvennyh sredstv [Journal of pharmaceuticals quality assurance issue] 2023; 1(39): 51-60. (In Russ.)
7. Krasnjuk I.I. (ml.), Naryshkin S.R., Beljackaja A.V., Tarasov V.V., Stepanova O.I., Krasnjuk I.I., Grih V.V., Ovsjannikova L.V., Mazjarkin E.V., Vorob'jov A.N. Metronidazol – 60 let primenenija. [Metronidazole – 60 years of use]. Vestnik Voronezhskogo gosudarstvennogo universiteta. Serija: Himija. Biologija. Farmacija [Bulletin of the Voronezh State University. Series: Chemistry. Biology. Pharmacy] 2020; 1: 81-90. (In Russ.)
